SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    No more pot-line bling for Canopy

    By

    Less than two years after announcing a partnership with rapper Drake, Canopy has ended the relationship.

    “We have indeed divested from More Life and the facility in Scarborough which had been intended to be part of that agreement is now Canopy Growth’s R&D facility, where we will work on plant science and science development projects,” a Canopy spokesperson told BNN Bloomberg.



    COVID casualty

    From Jay-Z to Jim Jones to Lil Wayne, there’s no shortage of rappers in the cannabis game. But perhaps after experiencing challenges with its former Leafs by Snoop (now LBS) brand with Snoop Dogg, Canopy and Drake were planning something different from a straightforward weed brand.

    “In many regards, at its essence, it’s almost a real estate play where More Life is going to do a lot of activity on cannabis destinations,” CEO David Klein told BNN Bloomberg in August. “I don’t know if that still fits anybody’s way of thinking, at least in the COVID world.”

    Wellness wins

    Canopy also has no shortage of celebrity partnerships already in the works, albeit more focused on the COVID-friendly wellness side. The company recently announced it was taking its partnership with Martha Stewart to a new level, appointing her to strategic advisor status with the company. And while Seth Rogen’s Houseplant brand may not be taking off in Canada, the premium flower brand seems to be well-received in California so far.

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    BofC

    Share Article

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free

    Related news